Kaplan-Meier analysis of 28 breast cancer patients treated postoperatively with chemotherapy

Copyright information:Taken from "Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance"Breast Cancer Research 2005;7(5):R862-R870.Published online 25 Aug 2005PMCID:PMC1242165.Copyright © 2005 Surowiak et al.; licensee BioMed Central Ltd. Patients with a lower overall immunoreactivity score for MDR1/P-glycoprotein (MDR1/P-gp) expression detected with antibody C219 exhibit significantly longer overall survival. Patients with a lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody JSB-1 exhibit significantly longer overall survival. Cyclooxygenase-2 (COX-2) negative cases exhibit significantly longer overall survival. Patients with lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody C219 exhibit significantly longer progression-free survival. Patients with lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody JSB-1 exhibit significantly longer progression-free survival. COX-2 negative cases exhibit significantly longer progression-free survival.